Adam S. Grossman is the CEO of ADMA Biologics, a position he has held since 2011. With over 20 years of experience in the blood and plasma industry, he has a strong background in launching new products and managing sales...
Adam S. Grossman is the CEO of ADMA Biologics, a position he has held since 2011. With over 20 years of experience in the blood and plasma industry, he has a strong background in launching new products and managing sales teams on national and international scales. Notably, he founded ADMA Biologics and served in key roles since its inception in 2007. His educational background includes a B.S. from Duke University and an M.B.A. from Harvard Business School, giving him a solid foundation in both science and business. Under his leadership, the company has focused on bringing innovative therapies to the market.